CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • CCM Dashboard
  • Financials
  • Filings
  • Institutional
  • Shorts
  • News
  • Reddit

Concord Medical Services (CCM)

Company Profile
Concord Medical Services Holdings Limited is a healthcare provider specializing in cancer care, research and prevention. The Company operates a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centres in China. The Company focuses on providing multidisciplinary cancer care approach in all areas of oncology services in its cancer hospitals. The Company also equips its hospitals with technologically advanced equipment such as the state-of-the-art proton therapy system in its Beijing, Shanghai and Guangzhou cancer hospitals. As of June 30, 2020, the Company operated a network of 27 centers based in 20 hospitals, spanning over 20 cities across 13 provinces and administrative regions in China. To ensure the commitment to the highest level of clinical care for patients, the Company offers ongoing education and training for doctors and other medical professionals in its network hospitals and centres in both local and overseas medical institutions.
Concord Medical Services logo

Company profile

Ticker
CCM
Exchange
NYSE
Website
www.concordmedical.com
CEO
Jianyu Yang
Employees
Incorporated
Cayman Islands
Location
China
Fiscal year end
Dec 31
Sector
Manufacturing > Dental Laboratories
Industry (SIC)
Services - Offices & Clinics of Doctors of Medicine
1life Healthcare • Airsculpt • Teladoc Health • Oncology Institute Inc • Medico International • Hims & Hers Health • LifeMD • HealthLynked • Healthcare Solutions Management • Cano Health ...
SEC CIK
0001472072
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Plans of Reorganization
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists

CCM stock data

Latest filings (excl ownership)
View all
6-K
Concord Medical Schedules 2022 Annual Meeting of Shareholders
25 Nov 22
6-K
Concord Medical Announces Changes in Management
30 Sep 22
6-K
Concord Medical Reports Financial Results for the First Half of 2022
23 Sep 22
6-K
Concord Medical Announces Its Subsidiary’s Application Filing for Potential Listing on The Stock Exchange of Hong Kong Limited
1 Jun 22
20-F
2021 FY
Annual report (foreign)
29 Apr 22
6-K
Concord Medical Reports Financial Results for the First Half of 2021
10 Dec 21
6-K
Concord Medical Schedules 2020 Annual Meeting of Shareholders
29 Nov 21
20-F
2020 FY
Annual report (foreign)
15 Oct 21
6-K
Concord Medical Completes RMB 400 Million Funding Round Led by Consortium Investors
23 Aug 21
6-K
Current report (foreign)
20 Aug 21
Latest ownership filings
View all
SC 13G/A
ZHOU Hao
16 Feb 21
SC 13D
Concord Medical Services Holdings Ltd
19 Mar 19
SC 13D/A
Concord Medical Services Holdings Ltd
19 Mar 19
SC 13G/A
Concord Medical Services Holdings Ltd
14 Feb 19
SC 13D/A
Concord Medical Services Holdings Ltd
16 Jan 19
SC 13G/A
Concord Medical Services Holdings Ltd
13 Feb 18
SC 13D/A
Concord Medical Services Holdings Ltd
14 Nov 17
SC 13D
Concord Medical Services Holdings Ltd
13 Nov 17
SC 13D/A
Concord Medical Services Holdings Ltd
23 May 17
SC 13D/A
Concord Medical Services Holdings Ltd
9 Feb 17

Financial summary

Financial statements Chart CCM financial data
Quarter (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Financial data from company earnings reports.

Institutional ownership, Q2 2022

CCM institutional ownership history Ownership history
55.1% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 4 4 –
Opened positions 1 1 –
Closed positions 1 0 NEW
Increased positions 0 0
Reduced positions 1 1 –
13F shares Current Prev Q Change
Total value 42.38 mm 42.39 mm -0.0%
Total shares 15.51 mm 15.52 mm -0.1%
Total puts 0.00 0.00
Total calls 0.00 0.00
Total put/call ratio – – –
Largest owners Shares Value Change
ZHOU Hao 15.38 mm $42.14 mm 0.0%
Renaissance Technologies 129.50 k $243.00 k -9.2%
C Citigroup 221.00 $0.00 NEW
BLK Blackrock 143.00 $0.00 0.0%
Proequities 0.00 $0.00
Largest transactions Shares Bought/sold Change
Renaissance Technologies 129.50 k -13.10 k -9.2%
UBS UBS Group AG - Registered Shares 0.00 -2.73 k EXIT
C Citigroup 221.00 +221.00 NEW
Proequities 0.00 0.00
BLK Blackrock 143.00 0.00 0.0%
ZHOU Hao 15.38 mm 0.00 0.0%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro
Why FARO Technologies Shares Are Trading Lower By 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
20 Jan 23
Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 133.1% to $0.2870. Helbiz recently announced discontinuation of operations in non-profitable markets.
12 Health Care Stocks Moving In Wednesday's Intraday Session
18 Jan 23
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
30 Dec 22
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the contemplated public offering.
12 Health Care Stocks Moving In Monday's Intraday Session
26 Dec 22
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
23 Dec 22

Press releases

From Benzinga Pro
Concord Medical Schedules 2022 Annual Meeting of Shareholders
25 Nov 22
BEIJING, Nov. 25, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education
Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson
16 Nov 22
BEIJING, Nov. 16, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE:CCM), a healthcare provider specialized in cancer treatment, research, education
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn